CDC Webinar: Overview of WFH Treatment Guidelines, 3rd Edition
On December 10th, 2020 Glenn Pierce, WFH VP Medical moderated this one-hour webinar in the Public Health Webinar Series on Blood Disorders presented by the CDC. The webinar discussed how the WFH Guidelines for the Management of Hemophilia, 3rd edition provides opportunities to improve the standard of diagnosis and care for people with hemophilia around […]
Complications of Hemophilia
This eLearning module presents Section 6 of the WFH Guidelines for the Management of Hemophilia: Complications of Hemophilia. Detailed illustrations, interactive features, a glossary, supplementary resources and self-quizzes bring to life the WFH recommendations regarding the management of inhibitors, as well as musculoskeletal and infection-related complications. Instructions Click on the “View Resource” button above to […]
Hemostatic Agents
This eLearning module presents Section 4 of the WFH Guidelines for the Management of Hemophilia: Hemostatic Agents. Detailed illustrations, interactive features, a glossary, supplementary resources and self-quizzes bring to life the WFH recommendations regarding FVIII and FIX clotting factor concentrates, fresh frozen plasma, cryoprecipitate, and other pharmacological options including DDAVP, tranexamic acid, and epsilon aminocaproic […]
New Developments in Treatment for Bleeding Disorders – Novel Therapies
New panel discussion: New Developments in Treatment for Bleeding Disorders – Novel Therapies, is a cure for hemophilia around the corner? While clotting factor concentrates remain, by far, the mainstay of the management of hemophilia, a number of novel therapies under development have the potential to dramatically change the treatment landscape. Leading hematologists and patient […]